Literature DB >> 16193287

Latent autoimmune diabetes in adults: a guide for the perplexed.

E A M Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16193287     DOI： 10.1007/s00125-005-1954-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  19 in total

1.  The discovery of type 1 diabetes.

Authors:  E A Gale
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

Authors:  T Tuomi; A Carlsson; H Li; B Isomaa; A Miettinen; A Nilsson; M Nissén; B O Ehrnström; B Forsén; B Snickars; K Lahti; C Forsblom; C Saloranta; M R Taskinen; L C Groop
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

3.  Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).

Authors:  T M E Davis; A D Wright; Z M Mehta; C A Cull; I M Stratton; G F Bottazzo; E Bosi; I R Mackay; R R Holman
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

Review 4.  Lawrence Lecture. The Emperor's new genes: 1993 RD Lawrence Lecture.

Authors:  J A Todd
Journal:  Diabet Med       Date:  1994 Jan-Feb       Impact factor: 4.359

Review 5.  Latent autoimmune diabetes in adults (LADA) should be less latent.

Authors:  S Fourlanos; F Dotta; C J Greenbaum; J P Palmer; O Rolandsson; P G Colman; L C Harrison
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

6.  High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

Authors:  K Decochez; J Tits; J L Coolens; L Van Gaal; G Krzentowski; F Winnock; E Anckaert; I Weets; D G Pipeleers; F K Gorus
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

7.  UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

Authors:  R Turner; I Stratton; V Horton; S Manley; P Zimmet; I R Mackay; M Shattock; G F Bottazzo; R Holman
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

8.  Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

Authors:  A Gottsäter; M Landin-Olsson; P Fernlund; A Lernmark; G Sundkvist
Journal:  Diabetes Care       Date:  1993-06       Impact factor: 19.112

9.  Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group.

Authors:  I Kockum; A Lernmark; G Dahlquist; A Falorni; W A Hagopian; M Landin-Olsson; L C Li; H Luthman; J P Palmer; C B Sanjeevi; G Sundkvist; I J Ostman
Journal:  Horm Metab Res       Date:  1996-07       Impact factor: 2.936

10.  Islet-cell antibodies in diabetes mellitus.

Authors:  R Lendrum; G Walker; A G Cudworth; C Theophanides; D A Pyke; A Bloom; D R Gamble
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321
View more
  43 in total

1.  Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!

Authors:  O Rolandsson; J P Palmer
Journal:  Diabetologia       Date:  2010-03-25       Impact factor: 10.122

2.  Declassifying diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2006-09       Impact factor: 10.122

3.  Latent autoimmune diabetes in adults (LADA)--more than a name.

Authors:  L Groop; T Tuomi; M Rowley; P Zimmet; I R Mackay
Journal:  Diabetologia       Date:  2006-07-04       Impact factor: 10.122

4.  Comment on: Gale EAM (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195-2199.

Authors:  A Clark; M Desai
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

Review 5.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 6.  Endocrine manifestations of hepatitis C virus infection.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Domenico Sansonno; Poupak Fallahi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

7.  The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.

Authors:  M Hillman; C Törn; M Landin-Olsson
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Islet inflammation and CXCL10 in recent-onset type 1 diabetes.

Authors:  B O Roep; F S Kleijwegt; A G S van Halteren; V Bonato; U Boggi; F Vendrame; P Marchetti; F Dotta
Journal:  Clin Exp Immunol       Date:  2010-01-05       Impact factor: 4.330

9.  Clustering of immunological, metabolic and genetic features in latent autoimmune diabetes in adults: evidence from principal component analysis.

Authors:  Giovanni Mario Pes; Alessandro Palmerio Delitala; Alessandra Errigo; Giuseppe Delitala; Maria Pina Dore
Journal:  Intern Emerg Med       Date:  2015-11-26       Impact factor: 3.397

10.  Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trøndelag Health Study.

Authors:  Elin Pettersen; Frank Skorpen; Kirsti Kvaløy; Kristian Midthjell; Valdemar Grill
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.